Impact of COVID-19 on people with multiple sclerosis
Real-world impact of the COVID-19 pandemic in people with multiple sclerosis
This study is looking at how the COVID-19 pandemic has affected people with multiple sclerosis, especially regarding their treatments and how well COVID-19 vaccines work for them, so we can better understand their health and social connections during this time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10757382 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic affects individuals with multiple sclerosis (MS), focusing on the risks associated with common MS treatments and the effectiveness of COVID-19 vaccines. It aims to fill knowledge gaps regarding the impact of the pandemic on MS patients' health and social connections. The study utilizes a collaborative network of MS centers and online surveys to gather real-time data from patients, alongside analyzing claims and electronic health records from a large cohort of insured MS patients. This approach allows for a comprehensive understanding of the pandemic's effects on this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who may be affected by the COVID-19 pandemic.
Not a fit: Patients without a diagnosis of multiple sclerosis or those not impacted by the COVID-19 pandemic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide critical insights that improve the management and treatment of multiple sclerosis during and after the COVID-19 pandemic.
How similar studies have performed: Other research has shown success in understanding the impact of pandemics on chronic conditions, making this approach both relevant and timely.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Xia, Zongqi — University of Pittsburgh at Pittsburgh
- Study coordinator: Xia, Zongqi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.